XML 9 R2.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Consolidated Income Statements - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Revenue $ 983.0 $ 824.0 $ 2,766.0 $ 2,305.0
Cost of sales (28.0) (36.0) (93.0) (113.0)
Gross profit (loss) 955.0 788.0 2,673.0 2,192.0
Research and development (533.0) (432.0) (1,525.0) (1,395.0)
Selling, general and administrative (247.0) (216.0) (727.0) (702.0)
Disposal, restructuring and other operating expenses, net 0.0 (6.0) 0.0 (6.0)
Total operating expense (780.0) (654.0) (2,252.0) (2,103.0)
Operating income (loss) 175.0 134.0 421.0 89.0
Income (loss) from equity investments, net 39.0 (1.0) 53.0 (13.0)
Interest income, net 28.0 28.0 89.0 80.0
Other non-operating income (loss), net 26.0 (15.0) 13.0 (2.0)
Income (loss) before income taxes 268.0 146.0 576.0 154.0
Income tax benefit (expense) (16.0) (59.0) 6.0 (72.0)
Net income (loss) $ 252.0 $ 87.0 $ 582.0 $ 82.0
Net income (loss) per share attributable to ordinary shareholders        
Basic (in USD per share) $ 0.24 $ 0.08 $ 0.56 $ 0.08
Diluted (in USD per share) $ 0.24 $ 0.08 $ 0.55 $ 0.08
Weighted average ordinary shares outstanding        
Basic (in shares) 1,052,000,000 1,027,000,000 1,049,000,000 1,026,000,000
Diluted (in shares) 1,064,000,000 1,049,000,000 1,062,000,000 1,040,000,000
External Customers        
Revenue $ 698.0 $ 576.0 $ 2,165.0 $ 1,755.0
Related Parties        
Revenue $ 285.0 $ 248.0 $ 601.0 $ 550.0